The Food and Drug Administration has approved a generic version of Teva Women's Health's Plan B One-Step, an emergency contraceptive that is availble over-the-counter without a prescription for women age 17 and older.
Watson Pharmaceuticals announced Friday that the FDA approved its Next Choice ONE DOSE, a lower-cost generic version that will launch "immediately," according to a press release.
Plan B One-Step sales took in $88 million for the 12 months ending May 31, according to IMS Health Data.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
